Filippo Lodi

18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial

Cristina Nanni, Lucia Zanoni, Cristian Vincenzo Pultrone et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 223 citations

Medicine, Nuclear Medicine, Oncology +9

68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy

Andrea Farolfi, Francesco Ceci, Paolo Castellucci et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 137 citations

Medicine, Nuclear Medicine, Oncology +17

Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging¹¹C-Choline PET/CT Scan Before Salvage Radiation Therapy?

Paolo Castellucci, Francesco Ceci, Tiziano Graziani et al. · Journal of Nuclear Medicine · 2014 · 122 citations

Medicine, Nuclear Medicine, Oncology +17

68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy

Francesco Ceci, Paolo Castellucci, Tiziano Graziani et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 109 citations

Medicine, Nuclear Medicine, Urology +17

11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series

Tiziano Graziani, Francesco Ceci, Paolo Castellucci et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 89 citations

Medicine, Nuclear Medicine, Radiology +13